Results 71 to 80 of about 3,762 (157)

Statin-Associated Autoimmune Myopathy: Current Perspectives

open access: yesTherapeutics and Clinical Risk Management, 2020
Eleni Tiniakou Johns Hopkins University School of Medicine, Department of Medicine, Division of Rheumatology, Baltimore, MD, USACorrespondence: Eleni TiniakouJohns Hopkins University School of Medicine, 5200 Eastern Avenue, Mason Lord, Center Tower ...
Tiniakou E
doaj  

Anti-Signal Recognition Particle Myopathy in a Geriatric Patient

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2015
Anti-signal recognition particle (SRP) myopathy is a rare idiopathic inflammatory myositis that usually affects middle-age women, and is characterized by rapidly progressive proximal and symmetrical muscle weakness, elevated creatine kinase levels ...
Diana Marques Ferreira   +4 more
doaj   +1 more source

Deep venous thrombosis in an individual with statin-exposed anti-SRP myopathy: case report and review of literature

open access: yesThrombosis Journal, 2021
Background Immune-mediated necrotizing myopathy (IMNM) is characterized by proximal muscle weakness, elvated serum muscle enzyme levels, myopathic electromyography findings, and necrotic muscle fiber with few inflammatory cell infiltration in muscle ...
Jiali Li   +5 more
doaj   +1 more source

Signal Recognition Particle Myopathy With Cardiac Manifestations in Rheumatoid Arthritis

open access: yesAnnals of Internal Medicine: Clinical Cases
Immune-mediated necrotizing myopathy is a rare inflammatory myopathy characterized by progressive muscle weakness and potentially severe systemic complications.
Priya Sunkara   +3 more
doaj   +1 more source

Anti-HMG-CoA reductase myopathy, an undesirable evolution of statin induced myopathy: a case report

open access: yesJournal of Community Hospital Internal Medicine Perspectives, 2019
Statins are commonly used lipid lowering agents which play a pivotal role in reducing cardiovascular morbidity and mortality. Often well tolerated, these HMG-CoA reductase (HMGCR) inhibitors can sometimes cause severe muscle weakness and elevated ...
Sunita Upreti   +2 more
doaj   +1 more source

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Comprehensive Review of Types, Pathophysiology, and Treatment Approaches

open access: yesBrain and Behavior, Volume 16, Issue 5, May 2026.
Chronic inflammatory demyelinating polyneuropathy is an autoimmune disorder causing demyelination, leading to distal weakness, sensory loss, and autonomic dysfunction. Immune activation triggers macrophage‐mediated myelin damage and conduction failure.
Ayesha Khan   +11 more
wiley   +1 more source

Sarcoid Nodular Myopathy Presenting With Hypercalcemia: A Rare Presentation—Case Report

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT An 18‐year‐old female patient with no past medical history presented with nonanginal chest pain 2 months after her delivery. She did not report any other symptoms such as cough, dyspnea, nausea, or vomiting. Her vital signs were stable. The only positive finding on physical examination was tenderness and edema, with a palpable lump on her ...
Vahideh Sadra   +4 more
wiley   +1 more source

Immune-Mediated Necrotizing Myopathy: A Review for Clinicians

open access: yesJournal of Electrodiagnosis and Neuromuscular Diseases, 2022
Immune-mediated necrotizing myopathy (IMNM) is a group of inflammatory myopathies showing necrotic and regenerating fibers without noteworthy inflammatory cell infiltration on pathology. The pathologic findings are different from those of dermatomyositis or sporadic inclusion body myositis.
openaire   +1 more source

Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on Autoimmunity and Cancer [PDF]

open access: yesFrontiers in Immunology, 2017
Autoimmune myopathies (myositides) are strongly associated with malignancy. The link between myositis and cancer, originally noticed by Bohan and Peter in their classification in 1975 (1), has been evidenced by large population-based cohort studies and a recent meta-analysis.
Audrey Aussy   +3 more
openaire   +5 more sources

The Role of Extracorporeal Membrane Oxygenation in Cardiopulmonary Dysfunction Due to Rheumatologic Diseases: A Systematic Review

open access: yesACR Open Rheumatology, Volume 8, Issue 4, April 2026.
Objective This systematic review documents the current status of extracorporeal membrane oxygenation (ECMO) use in patients with complications of rheumatologic diseases. Methods Following Preferred Reporting Items for Systematic Reviews and Meta Analyses 2020 guidelines, we conducted a systematic review of studies published from January 2019 to ...
Kari L. Falaas   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy